CTT Pharma wins US patent for micelle-based nicotine, vitamins, caffeine delivery technology
CTTH•U.S. patent granted for micelle delivery technology
CTT Pharmaceutical Holdings won a U.S. patent for a continuation-in-part covering micelle delivery technology for nicotine, vitamins, and caffeine.
Patent issuance is scheduled for Aug. 11, 2026, with a patent number already assigned by the U.S. Patent Office.
Coverage supports use in dissolvable oral formats such as strips, gum, pouches, lozenges, and dissolving tablets.
